Eliquis (Apixaban) for Oral Administration
We are seeking supplies of the oral medication Eliquis (active ingredient apixaban) for treating patients in approved indications. This is for the supply of patients at the Institute for Clinical and Experimental Medicine.
CONTRACTING AUTHORITY
Name
Institut klinické a experimentální medicíny
City
Praha
Country
CZ
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33621100, Antithrombotic agents.
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
Yes
Electronic Submission
Required
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
18 days remaining(LOT-0001)
Published